Glioblastomas represent one of the most formidable challenges in modern oncology, remaining largely incurable despite decades of intensive research. These…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…
Read More
Glioblastoma Research Reveals Cancer Reshapes Skull Bone and Disrupts Systemic Immune Response to Fuel Tumor Growth
The traditional understanding of glioblastoma multiforme (GBM) as a localized malignancy confined within the blood-brain barrier is being fundamentally challenged…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…
Read More
Localized Immune Reservoirs in the Skull Offer New Hope for Glioblastoma Treatment While Challenging Conventional Surgical Approaches
In a discovery that challenges decades of immunological dogma, researchers from the German Cancer Consortium (DKTK) at the West German…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…
Read More
UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing
Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…
Read More
Canadian Researchers Identify Potential Breakthrough in Glioblastoma Treatment Using Repurposed HIV Medication
A collaborative team of scientists from McMaster University and The Hospital for Sick Children (SickKids) has uncovered a significant biological…
Read More
Researchers Uncover Glioblastoma’s Systemic Impact on the Skull and Immune System Challenging Current Treatment Paradigms
A groundbreaking study led by researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of…
Read More
Canadian Researchers Identify Existing HIV Drug as Potential Breakthrough Treatment for Aggressive Glioblastoma Brain Cancer
In a significant advancement for neuro-oncology, a collaborative team of scientists in Canada has uncovered a novel mechanism to impede…
Read More
